Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Diabetic Peripheral Polyneuropathy
NCT00231673Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jul 2001
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of topiramate in peripheral polyneuropathy, sponsored by Johnson & Johnson. Started Jul 2001; status: completed.
02
Drugs
topiramate
03
Conditions
peripheral polyneuropathy
Beyond the preview
Go deeper on NCT00231673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231673.